Exposure–response modeling of the effect of glasdegib on cardiac repolarization in patients with cancer (Open Access)
The QTc modeling we performed for glasdegib was published in the Expert Review of Clinical Pharmacology.
Link to this article: https://doi.org/10.1080/17512433.2021.1925538
Citation: Luke K. Fostvedt, Naveed Shaik, Giovanni Martinelli, Andrew J. Wagner
& Ana Ruiz-Garcia (2021) Exposure–response modeling of the effect of glasdegib on cardiac
repolarization in patients with cancer, Expert Review of Clinical Pharmacology, 14:7, 927-935, DOI:
10.1080/17512433.2021.1925538
ABSTRACT
Purpose: To characterize the effect of glasdegib on cardiac repolarization (QTc) in patients with
advanced cancer.
Methods: A concentration–QTc model was developed using data from two glasdegib single-agent,
dose-escalation trials. Triplicate electrocardiogram was performed at pre-specified timepoints paired
with pharmacokinetic blood collections after a single dose and at steady-state. Changes in QTc from
baseline were predicted by model-based simulations at the clinical dose (100 mg QD) and in
a supratherapeutic setting.
Results: Glasdegib did not affect the heart rate, but had a positive effect on the corrected QT …